The Government has promised a National Cancer Plan this spring to hit the NHS target of 85 per cent for starting therapies ...

More than half of all men with Klinefelter syndrome (KS) are unaware that they have the condition. Among those who do receive ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

ADHD is a complex disorder. In the absence of clear guidelines, there is growing uncertainty and frustration among clinicians ...

As a consequence of the transfer of its Jyseleca® business to Alfasigma, the revenues and costs related to Jyseleca® for the full years 2024 and 2023 are presented separately from the results of the ...

My 36-year-old sister recently noticed an unusual mole on her shoulder. She is scheduled for some tests. Her primary care physician believes it might be melanoma. What ...

While melanoma is much less common than other types of skin cancer, it is the most serious because it is more likely to ...

It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...

Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression ...

Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...